Richard D. Bukoski
- Pharmacology top 2%
- Cannabis and Cannabinoid Research 3
- Nephrology top 5%
- Physiology top 5%
- Nitric Oxide and Endothelin Effects 18
- Adenosine and Purinergic Signaling 3
- Toxicology top 5%
-
- Neuropeptides and Animal Physiology 6
-
- Vitamin D Research Studies 5
- Cardiac Ischemia and Reperfusion 3
-
- Cardiovascular, Neuropeptides, and Oxidative Stress Research 4
-
- Eicosanoids and Hypertension Pharmacology 4
Richard D. Bukoski
45 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 91
- Endocrine and Autonomic Systems 165
- Pharmacology 383
- Nephrology 151
- Physiology 465
- Toxicology 51
Countries citing papers authored by Richard D. Bukoski
This map shows the geographic impact of Richard D. Bukoski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard D. Bukoski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard D. Bukoski more than expected).
Fields of papers citing papers by Richard D. Bukoski
This network shows the impact of papers produced by Richard D. Bukoski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard D. Bukoski. The network helps show where Richard D. Bukoski may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Richard D. Bukoski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 12 | |
| 2 | 2006 | 9 | |
| 3 | 2005 | 1 | |
| 4 | 2001 | 14 | |
| 5 | 2001 | 9 | |
| 6 | 1999 | 25 | |
| 7 | 1998 | 39 | |
| 8 | 1998 | 36 | |
| 9 | 1994 | 16 | |
| 10 | 1994 | 11 | |
| 11 | 1993 | 8 | |
| 12 | 1993 | 16 | |
| 13 | 1993 | 14 | |
| 14 | 1993 | 41 | |
| 15 | 1992 | 41 | |
| 16 | 1991 | 15 | |
| 17 | 1991 | 7 | |
| 18 | 1990 | 57 | |
| 19 | 1989 | 5 | |
| 20 | 1986 | 4 |
About Richard D. Bukoski
Richard D. Bukoski is a scholar working on Physiology, Physiology and Pathology and Forensic Medicine, having authored 45 papers that have together received 1.4k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (18 papers), Neuropeptides and Animal Physiology (6 papers), Vitamin D Research Studies (5 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (4 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Cannabis and Cannabinoid Research (3 papers), Adenosine and Purinergic Signaling (3 papers) and Cardiac Ischemia and Reperfusion (3 papers). The work is most often cited by research in Endocrine and Autonomic Systems (165 citations), Pharmacology (383 citations) and Nephrology (151 citations). Richard D. Bukoski has collaborated with scholars based in United States, France and Norway. Frequent co-authors include David A. McCarron, Hong Xue, Maria Mupanomunda, Ka Bian, George Kunos, László Offertáler, Sándor Bátkai, Yanlin Wang, Ken Mackie and Murray A. Rudd. Their work appears in journals such as Journal of Hypertension, American Journal of Hypertension, Hypertension, American Journal of Physiology-Heart and Circulatory Physiology and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.